HTG Molecular Appoints Dr. Maureen T. Cronin as Chief Scientific Officer and Senior Vice President
TUCSON, Ariz. , Oct. 31, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced the appointment of Maureen T. Cronin , Ph.D., as the Company’s Chief Scientific Officer
- Category:
- Press Releases